Tivozanib
Tivozanib is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including FOTIVDA. Available dosage form: capsule.
Drug Details
- Generic Name
- Tivozanib
- Brand Names
- FOTIVDA
- Application Number
- NDA212904
- Sponsor
- AVEO Pharmaceuticals, Inc.
- NDC Codes
- 6
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- TIVOZANIB HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. ( 1 )